Promising Antiviral Herbal and Medicinal Plants (PDF)

in biotech research and development. He has carried out research projects and consultancy work in the areas of plant-microbe interaction/ bioassay-guided drug-discovery and development, food security/sustainable agriculture and waste water treatment. Presently he is working as Assistant Professor at University Institute of Biotechnology, Chandigarh University, Gharuan Mohali, Punjab. Formerly, he was worked as Research Scientist at Agpharm Bioinnovations LLP incubated at Thapar Institute of Engineering & Technology, Patiala, India. Dr. Dwibedi's work is directed towards the development of screening platforms for different biological activities such as anti-microbial, anti-oxidant, anti-cancer, or finding novel molecules that interfere in the mechanism of development of diseases such as Alzheimer Dementia (AD), Parkinson disease (PD), Obesity, Anti-gout (arthritis) and type 2 diabetes. He is also interested in food security, which predominantly involves the exploitation of plant-microbe interaction to combat abiotic stress and post-harvest preservation to enhance the shelf life of fresh crop/horticulture produces.

Santosh Kumar Rath is a medicinal and natural product chemist with more than 10 years of experience in research, academia, and industry. Dr. Rath received his doctorate from AcSIR at CSIR-Institute of Minerals and Materials Technology (CSIR-IMMT), Bhubaneswar, India. Presently he is working as Assistant Professor at Department of SoPPHI, Faculty of Pharmacy, DIT University, Dehradun, Uttarakhand, India. His areas of research are Natural Product Chemistry and Organic Synthesis, in which he has expertise in isolation, identification, and characterization of bioactive secondary metabolites, structural modification of major chemical constituents from plants as well as fungal sources. His research areas involve multistep synthesis of biologically active synthetic and/or natural product-based hybrid scaffolds for lead identification in special targets to neurological disease, cancer, HIV, Covid-19, and infectious diseases. His research is mainly focused on the synthesis of novel P-gp and bacterial efflux pump inhibitors, besides synthetic modifications of the bioactive natural products for better activity/minimize toxicity profiles. Currently, he is developing new synthetic methodologies for C-H functionalization of heterocycles and other medicinally relevant molecules.